SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-21-021236
Filing Date
2021-06-16
Accepted
2021-06-16 16:48:22
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 nt10025805x1_s3.htm S-3 549616
2 EXHIBIT 5.1 nt10025805x1_ex5-1.htm EX-5.1 9374
3 EXHIBIT 10.1 nt10025805x1_ex10-1.htm EX-10.1 218272
4 EXHIBIT 23.1 nt10025805x1_ex23-1.htm EX-23.1 1952
5 logo_cyclerion-c.jpg GRAPHIC 69644
6 logo_cyclerion-cx1.jpg GRAPHIC 95821
7 nt10025805x1_ex5-1img01.jpg GRAPHIC 12332
  Complete submission text file 0001140361-21-021236.txt   1024848
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-257145 | Film No.: 211022058
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences